Founded by exited entrepreneurs, Science Creates is a Deep Tech ecosystem that enables scientists and engineers to turn their groundbreaking discoveries into disruptive businesses that can revolutionise the health of people and the planet.
By backing founders, we're building capability in the critical technologies — from engineering biology to quantum — that drive economic growth and create the high-skilled jobs of the next decade.
We support our startup community with specialised lab space, expert training and mentoring, a network of partner organisations, and access to investment opportunities. Through our independent charity and public events, we inspire the next generation of scientists and entrepreneurs.




.webp)

Our ethos
We believe the next big breakthroughs will emerge at the intersection of fields like quantum, AI, and biotechnology — and that spinouts are the most powerful way to turn those innovations into global impact.
The first step is empowering those at the forefront of knowledge with the right infrastructure, training, resources and investment.
Science Creates is laying the foundations for bold ideas and innovation to thrive and scale, nationwide.
Designed for flexibility, OMX, our new 30,000 sq ft of lab, office, and meeting space for startups and scaleups is now ready to take new tenants.
We currently welcome applications from service providers working in legal, IT, grants, cloud, bespoke software and marketing.
We invest in Deep Tech at the pre-seed and seed stages — and our endgame is global impact.



Our focus
Deep Tech refers to innovations based on major breakthroughs in science and engineering, often built on years of research and proprietary technology to solve global challenges. Unlike regular tech, it focuses on transformative, long-term solutions in fields like AI, quantum, engineering biology and advanced materials — the UK government's designated frontier industries.
Deep Tech can revolutionise entire industries, create high-skilled jobs and unlock new economic growth while improving lives.
We specialise in Deep Tech because the social, environmental and economic returns are proportional to the ambition. It demands patient capital and deep technical understanding, and that's exactly what we're built to provide.

GenomeKey is transforming how healthcare clinicians diagnose and treat infections like sepsis to improve patient outcomes. Using cutting-edge machine learning and DNA sequencing, the company is developing a next-generation diagnostic device to identify bacterial genomes and determine their antimicrobial susceptibility directly from patient blood in just a few hours, rather than days. This enables clinicians to prescribe the right antibiotics for patients with much more efficiency and accuracy, reducing costs, minimising unnecessary antibiotic use and ultimately saving millions of lives from the world’s leading cause of death.

Cambridge RNA Technologies is developing long-term RNAs (ltRNAs) - engineered RNA molecules that persist for weeks or months rather than hours. By combining the safety of RNA with durability previously only achievable through genome modification, ltRNAs enable durable therapeutic gene expression for protein replacement, immune cell engineering, and regenerative medicine without the risks of permanent genomic changes.

EnsiliTech is improving the shelf-life and global accessibility of vaccines and other biological therapeutics by combatting cold chain transport and storage issues. Its novel ensilication technology, designed for both existing and new biopharmaceutical formulations, encases thermally unstable biomolecules within silica nanoshells to prevent environmental degradation. This eliminates the need for cold chain requirements that are expensive, prone to failure and generate significant carbon dioxide emissions.



Our versatile spaces can welcome a variety of events, from small meetings to 60-person seminars including catering and a fully licensed bar.
